PLK inhibitors come of age in pediatric brain tumors

Neuro Oncol. 2022 Mar 12;24(3):427-428. doi: 10.1093/neuonc/noab298.

Authors

Shinji Maegawa¹, Vidya Gopalakrishnan^{2

3

4}

Affiliations

¹ Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
³ Brain Tumor Center, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁴ Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Brain Neoplasms* / drug therapy
Cell Cycle Proteins
Child
Humans
Protein Serine-Threonine Kinases*

Substances

Cell Cycle Proteins
Protein Serine-Threonine Kinases